CCL4 enhances preosteoclast migration and its receptor CCR5 downregulation by RANKL promotes osteoclastogenesis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-4889
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
CCL4 enhances preosteoclast migration and its receptor CCR5 downregulation by RANKL promotes osteoclastogenesis ; volume:9 ; number:5 ; day:2 ; month:5 ; year:2018 ; pages:1-12 ; date:5.2018
Cell death & disease ; 9, Heft 5 (2.5.2018), 1-12, 5.2018
- Urheber
-
Lee, Dabin
- Beteiligte Personen und Organisationen
-
Shin, Kyung-Ju
Kim, Dong Wook
Yoon, Kyung-Ae
Choi, Young-Jin
Lee, Bom Nae Rin
Cho, Je-Yoel
SpringerLink (Online service)
- DOI
-
10.1038/s41419-018-0562-5
- URN
-
urn:nbn:de:101:1-2018082200344370485953
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lee, Dabin
- Shin, Kyung-Ju
- Kim, Dong Wook
- Yoon, Kyung-Ae
- Choi, Young-Jin
- Lee, Bom Nae Rin
- Cho, Je-Yoel
- SpringerLink (Online service)
Ähnliche Objekte (12)
Attenuated RANKL-induced cytotoxicity by Portulaca oleracea ethanol extract enhances RANKL-mediated osteoclastogenesis
Cucumber seed polypeptides regulate RANKL-induced osteoclastogenesis through OPG/RANKL/RANK and NF-κB
Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling
Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL
The Notch1 signaling pathway directly modulates the human RANKL-induced osteoclastogenesis
Puerarin inhibits the osteoclastogenesis by inhibiting RANKL-dependent and –independent autophagic responses
(5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway
PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice
Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis
Monocrotaline Suppresses RANKL-Induced Osteoclastogenesis In Vitro and Prevents LPS-Induced Bone Loss In Vivo
Phosphorylation of BCL2 at the Ser70 site mediates RANKL-induced osteoclast precursor autophagy and osteoclastogenesis
Administration of zoledronic acid alleviates osteoporosis in HIV patients by suppressing osteoclastogenesis via regulating RANKL expression
Attenuated RANKL-induced cytotoxicity by Portulaca oleracea ethanol extract enhances RANKL-mediated osteoclastogenesis
Cucumber seed polypeptides regulate RANKL-induced osteoclastogenesis through OPG/RANKL/RANK and NF-κB
Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling
Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL
The Notch1 signaling pathway directly modulates the human RANKL-induced osteoclastogenesis
Puerarin inhibits the osteoclastogenesis by inhibiting RANKL-dependent and –independent autophagic responses
(5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway
PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice
Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis
Monocrotaline Suppresses RANKL-Induced Osteoclastogenesis In Vitro and Prevents LPS-Induced Bone Loss In Vivo
Phosphorylation of BCL2 at the Ser70 site mediates RANKL-induced osteoclast precursor autophagy and osteoclastogenesis
Administration of zoledronic acid alleviates osteoporosis in HIV patients by suppressing osteoclastogenesis via regulating RANKL expression
Attenuated RANKL-induced cytotoxicity by Portulaca oleracea ethanol extract enhances RANKL-mediated osteoclastogenesis
Cucumber seed polypeptides regulate RANKL-induced osteoclastogenesis through OPG/RANKL/RANK and NF-κB
Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling
Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL
The Notch1 signaling pathway directly modulates the human RANKL-induced osteoclastogenesis
Puerarin inhibits the osteoclastogenesis by inhibiting RANKL-dependent and –independent autophagic responses
(5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway
PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice
Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis
Monocrotaline Suppresses RANKL-Induced Osteoclastogenesis In Vitro and Prevents LPS-Induced Bone Loss In Vivo
Phosphorylation of BCL2 at the Ser70 site mediates RANKL-induced osteoclast precursor autophagy and osteoclastogenesis